Ticker
VRDNCompany Name
VIRIDIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -309.06M | $ -3.79 | 1 | 81.59M |
3/31/2025 | $ -279.75M | $ -3.44 | 1 | 81.34M |
12/31/2024 | $ -232.32M | $ -3.42 | 1 | 67.89M |
9/30/2024 | $ -196.99M | $ -2.97 | 1 | 66.42M |
6/30/2024 | $ -168.26M | $ -2.64 | 1 | 63.85M |
3/31/2024 | $ -167.42M | $ -2.74 | 1 | 61.1M |
12/31/2023 | $ -184.17M | $ -4.12 | 1 | 44.76M |
9/30/2023 | $ -180.21M | $ -4.13 | 1 | 43.65M |
6/30/2023 | $ -161.9M | $ -3.74 | 1 | 43.25M |
3/31/2023 | $ -134.77M | $ -3.19 | 1 | 42.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for VIRIDIAN THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -28.15M ] / (Shares WA [ 3.72M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -7.57 ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.65 |
median | $ 0.89 |
std | $ 3.42 |